Wells Fargo’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-90,495
| Closed | -$1.33M | – | 7189 |
|
|
2025
Q3 | $1.33M | Buy |
90,495
+15,123
| +20% | +$154K | ﹤0.01% | 3604 |
|
|
2025
Q2 | $740K | Buy |
75,372
+805
| +1% | +$6.67K | ﹤0.01% | 3881 |
|
|
2025
Q1 | $542K | Buy |
74,567
+24,229
| +48% | +$212K | ﹤0.01% | 4036 |
|
|
2024
Q4 | $394K | Buy |
50,338
+11,203
| +29% | +$92.2K | ﹤0.01% | 4342 |
|
|
2024
Q3 | $290K | Sell |
39,135
-16,544
| -30% | -$139K | ﹤0.01% | 4335 |
|
|
2024
Q2 | $446K | Sell |
55,679
-45,835
| -45% | -$409K | ﹤0.01% | 3987 |
|
|
2024
Q1 | $1.18M | Buy |
101,514
+15,659
| +18% | +$173K | ﹤0.01% | 3341 |
|
|
2023
Q4 | $959K | Sell |
85,855
-75,316
| -47% | -$692K | ﹤0.01% | 3452 |
|
|
2023
Q3 | $2.49M | Buy |
161,171
+6,617
| +4% | +$111K | ﹤0.01% | 2631 |
|
|
2023
Q2 | $2.93M | Buy |
154,554
+101,130
| +189% | +$1.78M | ﹤0.01% | 2594 |
|
|
2023
Q1 | $814K | Buy |
53,424
+53,202
| +23,965% | +$694K | ﹤0.01% | 3515 |
|
|
2022
Q4 | $2.83K | Buy |
222
+40
| +22% | +$360 | ﹤0.01% | 5922 |
|
|
2022
Q3 | $1K | Buy |
182
+125
| +219% | +$549 | ﹤0.01% | 6325 |
|
|
2022
Q2 | $0 | Sell |
57
-84
| -60% | -$254 | ﹤0.01% | 6977 |
|
|
2022
Q1 | $1K | Sell |
141
-3,511
| -96% | -$22.6K | ﹤0.01% | 6785 |
|
|
2021
Q4 | $48K | Buy |
+3,652
| New | +$57.7K | ﹤0.01% | 5983 |
|
|
2021
Q3 | – | Sell |
-123
| Closed | -$2K | – | 7088 |
|
|
2021
Q2 | $2K | Sell |
123
-2,409
| -95% | -$53.8K | ﹤0.01% | 6535 |
|
|
2021
Q1 | $60K | Sell |
2,532
-17,294
| -87% | -$399K | ﹤0.01% | 5732 |
|
|
2020
Q4 | $483K | Buy |
19,826
+15,711
| +382% | +$402K | ﹤0.01% | 4544 |
|
|
2020
Q3 | $106K | Buy |
4,115
+63
| +2% | +$2K | ﹤0.01% | 5243 |
|
|
2020
Q2 | $81K | Buy |
4,052
+1,426
| +54% | +$34.7K | ﹤0.01% | 5320 |
|
|
2020
Q1 | $66K | Buy |
2,626
+2,387
| +999% | +$69.8K | ﹤0.01% | 5246 |
|
|
2019
Q4 | $6K | Buy |
+239
| New | +$6.65K | ﹤0.01% | 6000 |
|
Other funds holding ETNB
Wells Fargo's ETNB Position: Q4 2025 in Review
Wells Fargo sold out of 89bio (ETNB) in Q4 2025, closing a stake of 90,495 shares — an estimated $1.33M sold.
Wells Fargo first reported a position in ETNB in Q4 2019 and held it in 23 quarters. The position peaked at $2.93M in Q2 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- Wells Fargo reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- Wells Fargo sold 90,495 89bio shares in Q4 2025, an estimated $1.33M.
- Wells Fargo first reported a position in 89bio in Q4 2019 and held it in 23 quarters.
- Wells Fargo's 89bio position peaked at $2.93M in Q2 2023.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on Wells Fargo's 13F filing for Q4 2025, filed 13 Feb 2026.